Is PMR the Next Indication for Tocilizumab? | MedPage Today
Roche won't contest Hetero Drug's tocilizumab copy | Mint
:quality(90)/ "Roche | Actemra")
Roche | Actemra
Evaluation of the Tocilizumab therapy in human cancers: Latest evidence and clinical potential - Ghasemi - 2022 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library
WHO adds Roche's arthritis drug tocilizumab to COVID-19 medicines list | Reuters
Roche to boost Tocilizumab supply to meet rising demand in India - The Economic Times
Buy RoActemra (tocilizumab) Online • Price & Costs | Everyone.org
FDA Approves Roche's Tocilizumab As First Monoclonal Antibody For COVID-19 Treatment
Coronavirus : l'Actemra de Roche marque un point contre le Covid 19 | Les Echos
Health System News Teamwork Tackles Tocilizumab
Delhi HC Issues Order on Tocilizumab Shortage, Seeks Patent Working Information from Roche – Spicyip
Tocilizumab Injection Supply: Delhi HC asks Centre to hold meeting with Roche to ensure immediate supply of Tocilizumab - The Economic Times
Approval lapsed) RoActemra tocilizumab 200 mg/ 10mL concentrate for solution for infusion (Roche Germany) | Therapeutic Goods Administration (TGA)
Approval lapsed) RoActemra tocilizumab 80mg/4mL concentrate for solution for infusion (Roche Germany) | Therapeutic Goods Administration (TGA)
Approval lapsed) RoActemra tocilizumab 400 mg/ 20mL concentrate for solution for infusion (Roche Germany) | Therapeutic Goods Administration (TGA)
Actemra; coronavirus complications to be treated under Chinese approval
FDA Advisory No.2021-2407 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug Product “Tocilizumab Injection Actemra® 400 mg/ 20 mL” - Food and Drug Administration
USTC Global on X: "The mechanism of using Tocilizumab to cure severe patients of COVID-19. @NIH @CDC @DrAiLynTan #coronavirus #COVID19 #CoronavirusOutbreak #coronaviruskorea #ItalyCoronavirus #italylockdown #IranCoVidTruth #Tocilizumab https://t.co ...
WHO prequalifies Roche's tocilizumab as its first monoclonal antibody treatment for COVID-19 - Homeland Preparedness News
Roche gives Tocilizumab worth over Rs 40 crores to MoHFW - Express Pharma
Tocilizumab May Benefit Certain Severe COVID-19 Patients | MedPage Today
Roche Suspends Patents On Tocilizumab In LMICs After WHO Recommends It As Treatment For Severe COVID-19 - Health Policy Watch
Roche arthritis drug cuts deaths in hospitalized COVID-19 patients, study suggests | CBC News
FDA approves drug to treat CRS induced by CAR T-cell therapy | MDedge Hematology and Oncology
